Exploring antimicrobial lipopeptides as next-generation defenders against drug-resistant bacteria through innovative synthesis methods and applications.
Explore how 2,5-disubstituted 1,3,4-oxadiazole derivatives are designed as CYP51 inhibitors for antimicrobial activity through molecular docking and ADME prediction.